Imvax
-
Bryn Mawr’s John Furey Stays “Hands-On,” Bio-Tech Firm Triples in Size
It seemed the right thing for John Furey to do—take 20 years of experience in different pharma roles, including as…
Imvax

It seemed the right thing for John Furey to do—take 20 years of experience in different pharma roles, including as…